A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa - Related Studies

A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

This study has been completed.

Study NCT00455507. Last updated on October 29, 2008. Information provided by Kyowa Pharmaceutical

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Parkinson's Disease

2	Additional conditions recognized in this trial
		Parkinson Disease

3	More general conditions related to this trial
		Basal Ganglia Diseases
		Brain Diseases
		Central Nervous System Diseases
		Movement Disorders
		Nervous System Diseases
		Neurodegenerative Diseases
		Parkinsonian Disorders

4	Interventions listed in this trial
		Istradefylline
		Placebo

5	Sponsors listed in this trial
		Kyowa Hakko Kogyo Co., Ltd.